Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
OM1, founded in 2015 and headquartered in Boston, Massachusetts, is a technology and data company specializing in personalized medicine and real-world evidence research within the healthcare sector. The company offers innovative solutions for real-world data analytics, evidence generation, and AI-driven predictive medicine, aiming to transform patient data into actionable insights for healthcare providers and researchers.
Since its inception, OM1 has raised a total of $176.25 million in funding, demonstrating significant investor interest in its mission to revolutionize healthcare through data-driven approaches. The company's services are primarily utilized by pharmaceutical and medical device companies, positioning OM1 as a key player in the rapidly evolving healthcare technology landscape.
While there is currently no concrete information available regarding OM1's IPO prospects, the company's substantial funding and innovative approach to healthcare data analytics may generate interest among potential investors. However, it's important to note that any discussions about a possible OM1 IPO remain speculative at this time.
As with any private company, various factors could influence OM1's decision to go public, including market conditions, company growth, and strategic objectives. Investors interested in OM1 stock or looking to buy OM1 shares should keep an eye on official announcements from the company regarding any potential IPO plans.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While OM1's IPO prospects remain uncertain, investors interested in gaining exposure to innovative healthcare technology companies don't have to wait. At Linqto, we offer members access to interests in promising pre-IPO private companies, including potential leaders in the healthcare data analytics sector. Our platform allows you to diversify your portfolio with lower minimum investments, potentially benefiting from the growth of emerging industry pioneers like OM1 before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
